Published in
Wiley, British Journal of Haematology, 6(189), p. 1064-1073, 2020
DOI: 10.1111/bjh.16474
Links
Tools
Maintenance therapy with ex vivo expanded lymphokine‐activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
Journal article published in 2020 by
Ascensión López‐Díaz de Cerio,
Ricardo García‐Muñoz,
Esther Pena,
Ángel Panizo,
Jesús Feliu,
Pilar Giraldo,
Mercedes Rodríguez‐Calvillo,
Nicolás Martínez‐Calle 
,
María T. Olave,
Carlos Grande,
Marcio Andrade‐Campos,
Eva Bandrés,
Jorge M. Núñez‐Córdoba,
Susana Inogés ,
Carlos Panizo
,
María T. Olave,
Carlos Grande,
Marcio Andrade‐Campos,
Eva Bandrés,
Jorge M. Núñez‐Córdoba,
Susana Inogés ,
Carlos Panizo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 